These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 395558)

  • 21. Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways.
    Gilbert JA; Gianoukakis AG; Salehi S; Moorhead J; Rao PV; Khan MZ; McGregor AM; Smith TJ; Banga JP
    J Immunol; 2006 Apr; 176(8):5084-92. PubMed ID: 16585606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN-gamma has a protective role against thyroid-specific autoantibody production in severe combined immunodeficient (SCID) mice xenografted with Graves' thyroid tissue.
    Yoshikawa N; Mori S; Tokoro T; Ikehara S; Kumazawa H; Yamashita T; Nishikawa M; Inada M
    Thyroid; 1996 Oct; 6(5):437-43. PubMed ID: 8936668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease.
    Marcocci C; Vitti P; Lopez G; Santini F; Mammoli C; Fenzi GF; Pinchera A
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):109-19. PubMed ID: 2575468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Student abuse and Graves-basedow's disease: about a case].
    Ntyonga-Pono MP; Nsame D
    Pan Afr Med J; 2017; 26():15. PubMed ID: 28450994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study using FRTL-5 cell for detecting thyroid stimulating antibody activity in serum in patients with Graves disease].
    Li J; Gao H; Jin SX
    Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):392-4, 454. PubMed ID: 1684315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyrotropin binding inhibiting antibody (TBIAb) in Graves' disease.
    Cho WY; Choi HH; Chun HJ; Ahn IM
    Korean J Intern Med; 1988 Jan; 3(1):45-51. PubMed ID: 2908684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can stress induce dysimmune dysthyroidism?
    Conte-Devolx B; Vialettes B
    Ann Endocrinol (Paris); 2013 Dec; 74(5-6):483-6. PubMed ID: 24262983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Life events, daily stresses and coping in patients with Graves' disease.
    Kung AW
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):303-8. PubMed ID: 7758236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction of MHC and Gm in liability to autoimmune thyroid disease.
    Nagataki S
    Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report.
    Arai N; Inaba M; Ichijyo T; Kagami H; Mine Y
    J Med Case Rep; 2017 Jan; 11(1):9. PubMed ID: 28061802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.
    Nagayama Y; Kita-Furuyama M; Ando T; Nakao K; Mizuguchi H; Hayakawa T; Eguchi K; Niwa M
    J Immunol; 2002 Mar; 168(6):2789-94. PubMed ID: 11884447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxic Graves' disease with thyroid hemiagenesis: diagnosis using thyroid-stimulating immunoglobulin measurements.
    Shechner C; Kraiem Z; Zuckerman E; Dickstein G
    Thyroid; 1992; 2(2):133-5. PubMed ID: 1356055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid-stimulating immunoglobulins in ophthalmic Graves' disease.
    Teng CS; Smith BR; Clayton B; Evered DC; Clark F; Hall R
    Clin Endocrinol (Oxf); 1977 Mar; 6(3):207-11. PubMed ID: 404101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases.
    Takasu N; Yamada T; Sato A; Nakagawa M; Komiya I; Nagasawa Y; Asawa T
    Clin Endocrinol (Oxf); 1990 Dec; 33(6):687-98. PubMed ID: 1982861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation of pedigrees of 110 patients with Graves' disease and the clinical significance of determinations of antithyroid antibodies of their first-degree relatives.
    Wang DQ; Wang JZ; Ren JM; Zhou XT; Peng WC
    Chin Med J (Engl); 1994 Nov; 107(11):817-21. PubMed ID: 7867387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The HLA-DQ associations with Graves' disease in Chinese children.
    Wong GW; Cheng SH; Dorman JS
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):493-5. PubMed ID: 10468909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of tsh binding inhibiting antibodies (TBI-ab) and thyroid adenylate cyclase stimulating antibodies (TS-ab) in sera of patients with Graves' disease.
    Lattanzi V; Scardapane R; Ciampolillo A; Vincenti C; Giorgino R
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):55-60. PubMed ID: 3838478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
    Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.